Stock Research: Healius

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Healius

ASX:HLS AU0000033359
1
  • Value
    15
  • Growth
    3
  • Safety
    Safety
    42
  • Combined
    1
  • Sentiment
    4
  • 360° View
    360° View
    1
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Healius Limited is a healthcare company providing specialized pathology services across Australia. It operates in healthcare services, offering pathology services through brands like QML, Laverty, Dorevitch, and others. It operates in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia, Northern Territory, Tasmania, and South Australia. In the last fiscal year, the company had 10500 employees, a market cap of $357 million, profits of $1015 million, and revenue of $1164 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 1 (better than 1% compared with alternatives), overall professional sentiment and financial characteristics for the stock Healius are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Healius. The consolidated Value Rank has a low rank of 42 which means that the share price of Healius is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 58% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 3, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 3% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 15, which means that the company has a riskier financing structure than 85% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 4, which means that professional investors are more pessimistic about the stock than for 96% of alternative investment opportunities. ...read more

more
Index
ASX 200
ASX 300
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 37 63 83
Growth
3 9 5 79
Safety
Safety
15 1 6 6
Sentiment
4 1 1 56
360° View
360° View
1 1 4 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 3 5 71
Opinions Change
31 35 6 50
Pro Holdings
n/a 3 13 66
Market Pulse
15 6 3 10
Sentiment
4 1 1 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 37 63 83
Growth
3 9 5 79
Safety Safety
15 1 6 6
Combined
1 1 4 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
3 5 27 95
Price vs. Earnings (P/E)
85 79 83 71
Price vs. Book (P/B)
93 83 93 69
Dividend Yield
1 16 36 62
Value
42 37 63 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
14 1 39 4
Profit Growth
1 18 8 98
Capital Growth
55 18 24 45
Stock Returns
9 67 3 87
Growth
3 9 5 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
5 5 8 14
Refinancing
84 4 6 6
Liquidity
10 10 16 17
Safety Safety
15 1 6 6

Similar Stocks

Discover high‑ranked alternatives to Healius and broaden your portfolio horizons.

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Asahi Intecc

TSE:7747
Country: Japan
Industry: Health Care Supplies
Size: Medium
Full Stock Analysis

M3

TSE:2413
Country: Japan
Industry: Health Care Technology
Size: Medium
Full Stock Analysis

Suncorp

ASX:SUN
Country: Australia
Industry: Property & Casualty Insurance
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.